Intelligence · Patents
Patents expiring in 2035
Annual patent cliff calendar for 2035 — US pharmaceutical patents by expiration date.
- Patents
- 1,447
Quick answer
1,447 indexed pharmaceutical patents have expiration dates in 2035. Browse by soonest expiry with links to assignee companies and related drugs.
-
US 9023798
Cystinosin replacement factor
granted -
US 9023356
Treatment method using EGFR antibodies and SRC inhibitors and related formulations
granted -
US 9023984
Diagnostic and therapeutic target for autoimmune diseases and uses thereof
granted -
US 9023866
2-selenophene-4-quinolones as anticancer agents
granted -
US 9024069
NONOate derivatives and uses thereof
granted -
US 9023322
Chewing gum compositions comprising cannabinoids
granted -
US 9023858
Substituted pyrido[2,3-d]pyrimidines as delta-5-desaturase inhibitors
granted -
US 9023823
Micro-RNA's that regulate muscle cells
granted -
US 9023371
Drug releasing coatings for medical devices
granted -
US 9023809
Phenylalanine dipeptide derivatives, compositions and use thereof
granted -
US 9029413
Treatment of viral infections by modulation of host cell metabolic pathways
granted -
US 9028841
Synergistic bacterial compositions and methods of production and use thereof
granted -
US 9029521
EML4-ALK fusion gene
granted -
US 9029509
Antibodies and pharmaceutical compositions thereof which bind urokinase-type plasminogen activator receptor (uPAR)
granted -
US 9029502
Inhibitors of the epidermal growth factor receptor-heat shock protein 90 binding interaction
granted -
US 9029318
Peptides and compositions for prevention of cell adhesion and methods of using same
granted -
US 9029338
Lipid formulated compositions and methods for inhibiting expression of a gene from the ebola virus
granted -
US 9028842
Compositions and methods for treatment, research and therapeutic applications for malaria
granted -
US 9029342
Compositions of matter that reduce pain, shock, and inflammation by blocking linoleic acid metabolites and uses thereof
granted -
US 9028809
Compositions, methods and uses for expression of enterobacterium-associated peptides
granted -
US 9029344
Linked purine pterin HPPK inhibitors useful as antibacterial agents
granted -
US 9028877
Bioeffective krill oil compositions
granted -
US 9029536
Fused heterocyclic compounds
granted -
US 9029546
Pyrazolopyridine kinase inhibitors
granted -
US 9029394
2-phenyl-4-quinolones as anticancer agents
granted -
US 9029321
Methods and compositions for targeting adipose cells in mammals
granted -
US 9029388
Condensed heterocyclic compound
granted -
US 9028887
Method improve spatial memory via pterostilbene administration
granted -
US 9028819
Methods of alleviating itch by administering human antibodies to human protease-activated receptor 2
granted -
US 9029530
Detection of oligosaccharides
granted -
US 9029326
Polypeptides, nucleic acid molecule encoding polypeptides, and uses of polypeptides
granted -
US 9029557
Labeled A4B2 ligands and methods therefor
granted -
US 9029525
Compositions and methods for inhibiting expression of GSK-3 genes
granted -
US 9029550
Conformationally restricted urea inhibitors of soluble epoxide hydrolase
granted -
US 9028499
Bone cutting device
granted -
EP 2870969
Pharmazeutische Zusammensetzung zur Reduzierung der adipösen Masse
granted -
US 9033919
Medical device rapid drug releasing coatings comprising oils, fatty acids, and/or lipids
granted -
US 9035072
Process of producing cycloalkylcarboxamido-indole compounds
granted -
US 9035061
Process for preparing a biphenyl-2-ylcarbamic acid
granted -
US 9034588
Monoclonal antibody therapy for pancreas cancer
granted -
US 9034318
Chemically modified cystathionine beta-synthase enzyme for treatment of homocystinuria
granted -
US 9034336
Immunomodulators and immunomodulator conjugates
granted -
US 9034323
Method for control of post-prandial glucose
granted -
US 9034343
Attenuated human parainfluenza virus, methods and uses thereof
granted -
US 9034388
Bioeffective krill oil compositions
granted -
US 9034311
Pyridin-2(1 H)-one derivatives as JAK inhibitors
granted -
US 9034313
Nucleic acid molecules encoding rantes, and compositions comprising and methods of using the same
granted -
US 9034347
Drug delivery system and method for the treatment of neuro-degenerative disease
granted
Frequently asked questions
How many pharma patents expire in 2035?
1,447 published patents in our USPTO index have expiration dates falling in calendar year 2035.